Nanobiotix
NBTX
12 hedge funds and large institutions have $67.5M invested in Nanobiotix in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
73% more capital invested
Capital invested by funds: $39.1M → $67.5M (+$28.4M)
33% more funds holding
Funds holding: 9 → 12 (+3)
7.33% more ownership
Funds ownership: 12.35% → 19.67% (+7.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JJ
Johnson & Johnson
New Brunswick,
New Jersey
|
+$29.6M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$5.91M |
| 3 |
BlackRock
New York
|
+$1.38M |
| 4 |
Citigroup
New York
|
+$4.02K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$8.75M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$98K |
| 3 |
Morgan Stanley
New York
|
-$6.95K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.47K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.26K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JJ
1
Johnson & Johnson
New Brunswick,
New Jersey
| $40.9M | +$29.6M | +4,664,179 | +486% |
|
|
2
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $20.9M | +$5.91M | +932,835 | +48% |
|
|
PA
3
Perceptive Advisors
New York
| $4.04M | – | – | – |
|
|
4
BlackRock
New York
| $1.59M | +$1.38M | +218,515 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $22.6K | -$4.47K | -706 | -19% |
|
|
6
Citigroup
New York
| $4.62K | +$4.02K | +635 | New |
|
|
7
Morgan Stanley
New York
| $4.4K | -$6.95K | -1,096 | -64% |
|
|
8
Qube Research & Technologies (QRT)
London,
United Kingdom
| $2.5K | -$2.26K | -357 | -51% |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$1.93K | +305 | New |
|
|
GI
10
GAMMA Investing
Foster City,
California
| $1.33K | +$1.11K | +175 | New |
|
11
Bank of America
Charlotte,
North Carolina
| $1.03K | +$893 | +141 | New |
|
12
RhumbLine Advisers
Boston,
Massachusetts
| $240 | – | – | – |
|
|
AG
13
Artal Group
Luxembourg
| – | -$8.75M | -1,000,000 | Closed |
|
|
14
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$98K | -11,201 | Closed |
|
NBTX Hedge Fund Activity: Q4 2023 in Review
12 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q4 2023, worth a combined $67.5M — up 73% from $39.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NBTX positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Johnson & Johnson, adding an estimated $29.6M. The largest seller was Artal Group, exiting entirely with an estimated $8.75M sold.
- 12 institutional investors held Nanobiotix (NBTX) as of Q4 2023, up from 9 in Q3 2023.
- Funds reported $67.5M of Nanobiotix stock for Q4 2023, up 73% quarter-over-quarter.
- 5 funds opened new Nanobiotix positions in Q4 2023 and 2 closed out, a net change of +3 holders.
- The largest Nanobiotix buyer in Q4 2023 was Johnson & Johnson, an estimated $29.6M added.
- The largest Nanobiotix seller in Q4 2023 was Artal Group, an estimated $8.75M sold.
Based on aggregated 13F filings for Q4 2023.